One company that I have been consistently bullish about over the past few years is HCA Healthcare (NYSE: HCA ). If you're not familiar with the company, the most important thing to know about it is that it is Crude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential. Subscribers get to use a 50+ stock model account, in-depth cash flow analyses of E&P fi ...

The U.S. hospital industry has been in fine fettle over the past year. The industry has been witnessing several positive catalysts such as rising admissions, the resumption of elective procedures, cybersecurity and other technological advancements. The Zacks-defined Medical – Hospital Industry is currently in the top 1% of the Zacks Industry Rank. In the past year, the industry has provided a massive 61.1% return, while its year-to-date return is also impressive at 50.6%. Since it is ranked in the top half ...

HCA Healthcare (HCA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. Since a ch ...

One stock that might be an intriguing choice for investors right now is HCA Healthcare, Inc. (HCA) . This is because this security in the Zacks Medical – Hospital space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in t ...

Core Insights - Zacks Premium offers various tools for investors to identify stocks to buy, sell, and track hot industries [1] - The Focus List is a curated portfolio of 50 stocks aimed at long-term investors, expected to outperform the market over the next 12 months [3][4] Performance Metrics - The Focus List gained 13.85% in 2020, outperforming the S&P 500's return of 9.38% [5] - Cumulatively, the Focus List has returned 2,519.23% from February 1, 1996, to March 31, 2021, compared to the S&P's 854.95% [5] Methodology - Stocks for the Focus List are selected based on earnings estimate revisions, which reflect analysts' expectations of growth and profitability [6][7] - The Zacks Rank, a proprietary stock-rating model, uses changes in quarterly earnings expectations to help investors build a successful portfolio [8] Zacks Rank Factors - The Zacks Rank is based on four main factors: Agreement, Magnitude, Upside, and Surprise, which are recalculated nightly [9] - Stocks in the Focus List are primarily from 1 (Strong Buy) or 2 (Buy) ranked companies, indicating a bullish earnings consensus among analysts [9] Case Study: HCA Healthcare - HCA Healthcare, the largest non-governmental operator of acute care hospitals in the U.S., has seen its stock increase by 227.03% since being added to the Focus List [10][11] - The Zacks Consensus Estimate for HCA's fiscal 2024 earnings has increased by $1.49 to $22.46, with an expected earnings growth of 18.2% for the current fiscal year [11]

HCA Healthcare, Inc. (HCA) shares have gained 18.4% in the past three months, outperforming the hospital industry and the S&P 500 Index. Over this time frame, the industry and the S&P 500 Index have gained 16% and 2.2%, respectively. Currently priced at $403.43, the stock is less than 1% below its 52-week high. This proximity underscores investor confidence and market optimism about this hospital company's prospects. Moreover, the stock is trading above its 50-day and 200-day moving averages, signaling stro ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. Zacks Premium also includes the Zacks Style Scores. Wha ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Score ...

There are no certainties in equity markets, but these stocks look highly likely to deliver outsized returns. Some stocks look so attractive that they are hard to pass up. These are often industry leaders with robust underlying businesses, competitive edges, and plenty of growth potential. That describes Novo Nordisk (NVO 0.07%) and HCA Healthcare (HCA 1.48%) well. These two healthcare leaders have generally delivered aboveaverage returns, yet they have plenty left in the tank. For those with $1,000 to spare ...

Coca-Cola plastic bottle is seen in this illustration photo taken in Warsaw, Poland on August 16, ... [+] 2024. (Photo by Jakub Porzycki/NurPhoto via Getty Images) NurPhoto via Getty Images If you are a Coca-Cola investor and took advantage of the stock's reasonably strong performance in recent weeks following its better-than-expected Q2 earnings report, it may be time to look elsewhere. As of this moment, we find HCA Healthcare, an operator of healthcare facilities, and aerospace and defense major Lockheed ...